CORONA Remedies Limited (NSE:CORONA)

Market Cap	85.05B
Revenue (ttm)	12.99B
Net Income (ttm)	1.75B
Shares Out	61.16M
EPS (ttm)	28.62
PE Ratio	48.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	66,474
Average Volume	132,961
Open	1,448.00
Previous Close	1,458.80
Day's Range	1,379.20 - 1,456.60
52-Week Range	1,336.60 - 1,541.00
Beta	n/a
RSI	45.85
Earnings Date	n/a

About CORONA Remedies

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 4,508
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CORONA

Financial Performance

In 2024, CORONA Remedies's revenue was 11.96 billion, an increase of 17.93% compared to the previous year's 10.14 billion. Earnings were 1.49 billion, an increase of 65.11%.